The mentor team focuses on solving the major needs of clinical ophthalmic disease treatment, and constructs advanced ophthalmic biomimetic functional interfaces and nano-drug delivery carriers from the perspective of materials science, providing a new strategy for the management of clinical diseases. The specific research field are the surface biomimetic modification and functionalization of macro-scale ophthalmic biomaterials (intraocular lenses, contact lenses, glaucoma drainage tubes, etc.), micro-scale micro-environment intelligent response and construction of ophthalmic physiological barrier-penetrating nano-drug carriers, solving Ocular surface dry eye, corneal infection, and clinical problems such as diabetic retinopathy in the posterior segment of the eye, choroidal neovascularization, and macular edema. In the past 5 years, the research team has received 5 national-level project support, more than 10 provincial and ministerial-level projects, and more than 5 million research funds are available for research. The team has 8 key faculty members, more than 30 graduate students, and published more than 70 SCI papers, including 1 Cell sub-journal, 6 papers with a score of more than 10, 3 papers were selected as ESI highly cited, and established cooperative relationships with top research groups nationally and internationally.

Dr. Jiang, Doctor of Medicine, the deputy chief physician of the Department of Ophthalmology, the First Affiliated Hospital of Wenzhou Medical University, the head of the department, and the tutor of master students. At present, he is the member of Ophthalmology Branch of Wenzhou Medical Association, Member of Ophthalmology Branch of Zhejiang Ultrasound Branch, Member of Refractive Group of China Physician Equipment Association. He has been engaged in ophthalmology for more than 20 years, and has studied ophthalmology at the Eye and ENT Hospital of Fudan University and the New England College of Optometry in the United States. He specializes in minimally invasive surgery for vitreoretinal diseases and phacoemulsification for cataract surgery. Dozens of papers have been published in internationally renowned journals Hypertension Research, Journal of Biochemistry and Eye and other SCI indexed journals and national journals. He has presided over two provincial natural science funding programs and three department-level programs.

Dr. Wang, a researcher and doctoral mentor of the School of Optometry and Biomedical Engineering of Wenzhou Medical University, the winner of Zhejiang Province Outstanding Youth Fund, the top young talent of Wenzhou Special Support Program, Wenzhou 551 Talent, the member of Chinese Medical Biotechnology Member of the Technical Association. He has long engaged in the research of surface interface modification and functionalization of ophthalmic biomaterials, committed to the construction of multi-scale bionic interface materials with biological functions, and the development of advanced ophthalmic drug delivery materials that penetrate physiological barriers. As the first/corresponding author, he has published more than 40 SCI-indexed papers in international academic journals such as Advanced Materials, Cell Reports Physical Science, Small, Chemical Engineering Journal, ACS Applied Materials & Interfaces, with an average impact factor of over 6.0, and has been cited more than 1,500 times. The H factor is 24, and authorized 10 national invention patents (5 authorized), 1 general project of the National Natural Science Foundation 1 youth project, 1 Zhejiang Provincial Outstanding Youth Fund project, and 1 major scientific and technological research project in Wenzhou.